Antiphospholipid antibodies and thrombosis: assessment of the potential risk for thrombosis
- 1 April 1996
- journal article
- review article
- Published by SAGE Publications in Lupus
- Vol. 5 (2) , 163-166
- https://doi.org/10.1177/096120339600500216
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen- PE complexBlood, 1995
- Antiphospholipid-protein antibodies: Laboratory detection and clinical relevanceThrombosis Research, 1995
- Antiphospholipid Antibodies in Vascular Surgery Patients A Cross-Sectional StudyAnnals of Surgery, 1994
- Anti-annexin antibody in the sera of patients with habitual fetal loss or preeclampsiaThrombosis Research, 1994
- Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state [see comments]Blood, 1993
- Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? [see comments]Blood, 1993
- Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous ThrombosisAnnals of Internal Medicine, 1992
- Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human ProthrombinThrombosis and Haemostasis, 1991
- Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).Proceedings of the National Academy of Sciences, 1990
- CORONARY ARTERY BYPASS GRAFT FAILURE—AN AUTOIMMUNE PHENOMENON?The Lancet, 1986